ARCHIVES

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Colon Cancer Survival Rates Differ Across Racial Lines

October 28, 2011

In Brief: Pursell Most Likely To Replace Conte, Foriend Of Cancer Program; DeVita Names Associate

February 15, 1991

In Brief: Immunologists Boycott USSR Trip; Centers Program Staff Reorganized, Trimmed Down

June 2, 1978

Colorectal, Lung Cancer Screening Techniques Show No Mortality Improvement, Conferences Find

December 1, 1978

Frelick To Receive ACCC Annual Award Will Leave NCI In July

March 6, 1987

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985